Pathophysiologic mechanisms and management of large granular lymphocytic leukemia associated pure red cell aplasia

13Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Large granular lymphocytic leukemia (LGLL) is a chronic clonal lymphoproliferative disease of mature T or NK cells, and produces a variety of hematological abnormalities. Pure red cell aplasia (PRCA) is a rare haematological disease and is one of the most common complications of LGLL. LGLL-associated PRCA may represent a relatively indolent type and may be more common than reported, but its natural history and clinical course have not been well described. The ethnic origin of the patients is an important consideration in determining the relationship between PRCA and LGLL. Guidelines and progresses for management of LGLL-associated PRCA rely on accumulation of empirical experiences, integrative analyses of several cases and clinical trials. The purpose of this review is to evaluate occurrence, possible mechanisms, diagnosis, clinical features, treatments and outcomes of LGLL-associated PRCA.

Cite

CITATION STYLE

APA

Qiu, Z. Y., Qin, R., Tian, G. Y., Wang, Y., & Zhang, Y. Q. (2019). Pathophysiologic mechanisms and management of large granular lymphocytic leukemia associated pure red cell aplasia. OncoTargets and Therapy. Dove Medical Press Ltd. https://doi.org/10.2147/OTT.S222378

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free